CArdiovascular Risk Assessment STudy in Lupus Erythemathodes (CASTLE)

CArdiovascular Risk Assessment STudy in Lupus Erythemathodes (CASTLE): Studie Zur Detektion Des kardiovaskulären Risikos in Patienten Mit Systemischem Lupus Erythematodes

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01520155

Acronym

CASTLE

Enrollment

Registered

2012-01-27

Start date

2011-12-31

Completion date

2012-12-31

Last updated

2013-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Lupus Erythematosus

Keywords

lupus erythematosus, cardiovascular risk

Brief summary

The key of this prospective study is to identify a potentially increased cardiovascular risk in patients with systemic Lupus erythematodes, with and without renal affection. Three groups of patients will be compared.

Detailed description

Key of this prospective study is to identify a potentially increased cardiovascular risk in patients with systemic Lupus erythematodes, with and without renal affection. Three group of patients will be compared as followed. First group are patients with known systemic Lupus erythematodes without renal affection, second group are patients with known systemic Lupus erythematodes with renal affection and the third group are patients with a non-autoimmun chronic kidney disease

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

* Patients with systemic Lupus erythematosus

Exclusion criteria

* Patients without systemic Lupus erythematosus

Design outcomes

Primary

Measure	Time frame	Description
Identification of cardiovascular risk in patients with systemic Lupus Erythematodes	one year	Identification of cardiovascular risk in patients with systemic Lupus Erythematodes

Countries

Germany

Outcome results